Recently in Know Error Category

The know error® system for breast biopsies will be participating at the Society of Breast Imaging's (SBI) next course -- Practical Breast MRI: Case Based Review." The course takes place January 28 - 29, 2012 at the Hilton Bonnet Creek Hotel in Orlando, FL. Look for our tabletop display in the registration area.

Know Error develops and markets the know error® system for breast biopsies which utilizes bar coding, forensic principles and DNA matching to confirm that the biopsy samples being evaluated belong to the patient being diagnosed. Available for a diverse range of tissue types, including breast, the know error® system brings new levels of patient safety and diagnostic accuracy to the biopsy evaluation process.

Since the company's launch in 2009, hundreds of physicians in a variety of specialties have incorporated the know error® system as a standard for their patient care. To learn more about the know error® system for breast biopsies, visit our website www.knowerror.com.

According to an article in the New York Post, a New York woman who was undergoing surgery for injuries caused in a car accident was misdiagnosed with Stage 4 metastatic breast cancer based on a lab's mishandling of her biopsy tissue. During routine post surgical tests, the woman's biopsy was contaminated with tissue from the sample of a patient who did have cancer. Since the diagnosis was Stage 4 cancer, her doctors recommended radiation treatment as soon as possible. However, after doctors were unable to pinpoint her type of cancer, they asked for a second opinion from a different lab. The new test revealed the misdiagnosis but not before she had already undergone 6 radiation treatments.

This is different than the chain of events leading to a misdiagnosis that have occurred in most cases covered in this blog. Typically, a lab mix up occurs which results in a false diagnosis, ultimately leading to unnecessary surgery and/or treatment for cancer. It is not until after the surgery that the routine post surgical tests of the biopsied tissue reveal there was no cancer in the first place. In this case, the testing of the post surgical biopsy tissue (from an unrelated surgery) was where the mistake and resulting misdiagnosis occurred.

Regardless of where the error occurred in the complex biopsy evaluation process, it is possible to avoid adverse outcomes such as these. Know Error develops and markets the know error® system which utilizes bar coding, forensic principles and DNA matching to confirm that the biopsy samples being evaluated belong to the patient being diagnosed. In this case, DNA testing conducted prior to treatment would have revealed two tissue types and that the one with cancer did not match this patient's DNA.

Available for a diverse range of tissue types, the know error® system brings new levels of patient safety and diagnostic accuracy to the biopsy evaluation process. Since the company's launch in 2009, hundreds of physicians in a variety of specialties have incorporated the know error® system as a standard for their patient care.

To learn more about the know error® system, visit our website www.knowerror.com.

The know error® system is exhibiting at RSNA 2011 -- the 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. The meeting is being held November 27th - December 2nd at McCormick Place in Chicago. Come see us at Booth 1006 in Hall D (Lakeside Center).

In addition to participating in the meeting, Know Error is a proud supporter of the RSNA Exhibitor Circle Program which supports and provides funding for the RSNA's Research and Education Foundation. The Foundation's mission is "to improve patient care by supporting research and education in radiology and related scientific disciplines through funding grants and awards to individuals and institutions that will advance radiologic research, education and practice."

Know Error develops and markets the know error® system which utilizes bar coding, forensic principles and DNA matching to confirm that the biopsy samples being evaluated belong to the patient being diagnosed. Available for a diverse range of tissue types, the know error® system brings new levels of patient safety and diagnostic accuracy to the biopsy evaluation process.

Since the company's launch in 2009, hundreds of physicians in a variety of specialties, including radiology, have incorporated the know error® system as a standard for their patient care. To learn more about the know error® system, visit our website www.knowerror.com.

Know Error is sponsoring the 2nd Annual Connecticut Challenge Survivorship Summit: "Bringing Together Leaders in Cancer Survivorship." This annual symposium will be held November 15, 2011 at the New Haven Lawn Club in New Haven, CT. The event is featuring speakers from world renowned cancer centers, including Memorial Sloan Kettering Cancer Center and the Abramson Cancer Center of the University of Pennsylvania. Kenneth Miller, MD, Director of the Lance Armstrong Foundation Adult Survivorship Program at Dana-Farber Cancer Institute and Instructor in Medicine at Harvard Medical School, will wrap up the program with a presentation titled: "Buy-in and Pushback: How survivorship fits into the system." Click here to learn more about this meeting.

The mission of the Connecticut Challenge is "to empower cancer survivors to live healthier, happier and longer lives."  According to its website, the Connecticut Challenge raised more than $1.4 million in 2010 with 86 cents of every dollar going towards program services and grants.

Know Error develops and markets the know error® system which utilizes bar coding, forensic principles and DNA matching to confirm that the biopsy samples being evaluated belong to the patient being diagnosed. Available for a diverse range of tissue types, including prostate and breast, the know error® system brings new levels of patient safety and diagnostic accuracy to the biopsy evaluation process.

Since the company's launch in 2009, hundreds of physicians in a variety of specialties have incorporated the know error® system as a standard for their patient care. To learn more about the know error® system, visit our website www.knowerror.com.

Know Error was a proud sponsor of the 5th Annual "Key to the Cure" event hosted by the St. Vincent Foundation and Saks Fifth Avenue. The event was held October 15th, 2011 at Saks Fifth Avenue at Keystone at the Crossing and was part of a nationwide Saks fundraising initiative to raise funds for cancer treatment and research. The proceeds from the Indianapolis event will benefit St. Vincent Cancer Care.  

The black-tie event included a cocktail reception, seated dinner, fashion show, live auction and dancing. According to the Indianapolis Star, the 2011 fundraiser raised close to $500,000 which will support important initiatives at St. Vincent Cancer Care. To date, the Saks Fifth Avenue and St. Vincent Foundation partnership has raised more than $2 million.

Know Error develops and markets the know error® system which utilizes bar coding, forensic principles and DNA matching to confirm that the biopsy samples being evaluated belong to the patient being diagnosed. Since the company's launch in 2009, hundreds of physicians in a variety of specialties have incorporated the know error® system as a standard for their patient care.

To learn more about the know error® system, visit our website www.knowerror.com.

The know error® system for prostate biopsies is exhibiting at a meeting of the Chicago Urological Society that will focus on prostate cancer. The meeting is being held November 9th, 2011 at the University Club of Chicago. Among other medical experts and urologists speaking at the event, the keynote speaker will be Alan Partin, MD, PhD, Urologist-in-Chief, Department of Urology at Johns Hopkins Hospital. Click here for more information on this meeting.

Know Error develops and markets the know error® system for prostate biopsies which utilizes bar coding, forensic principles and DNA matching to confirm that the biopsy samples being evaluated belong to the patient being diagnosed. Available for a diverse range of tissue types, including prostate, the know error® system brings new levels of patient safety and diagnostic accuracy to the biopsy evaluation process.

Since the company's launch in 2009, hundreds of physicians in a variety of specialties, including urology, have incorporated the know error® system as a standard for their patient care. To learn more about the know error® system for prostate biopsies, visit our website www.knowerror.com.

Know Error is hosting a User's Group Luncheon Meeting prior to the Large Urology Group Practice Association's 2011 Annual Meeting. The luncheon is being held on November 3rd, from 11:00 am - 2:00 pm, at the Drake Hotel in Chicago. Invitations have been extended to urologists attending LUGPA 2011.

A keynote presentation will be provided on the significance of DNA testing in the biopsy evaluation process, as well as an update and discussion on the know error® system's performance within large urology group practice settings.

"We Are Ready for a DNA Timeout"
John Pfeifer, MD, PhD, Vice Chairman for Clinical Affairs, Pathology and Immunology,
Washington University School of Medicine

"Know Error Best Practices"
Ann Anderson, MD, Director of Pathology, Integrated Medical Professionals

Know Error develops and markets the know error® system which utilizes bar coding, forensic principles and DNA matching to confirm that the biopsy samples being evaluated belong to the patient being diagnosed. Since the company's launch in 2009, hundreds of physicians in a variety of specialties, including urology, have incorporated the know error® system as a standard for their patient care.

To learn more about the know error® system for prostate biopsies, visit our website www.knowerror.com.

The know error® system for prostate biopsies will be showcased at the Annual Meeting of the Large Urology Group Practice Association (LUGPA). The meeting is being held November 3-5, 2011 at the Drake Hotel in Chicago. Click here to learn more about this meeting.

Know Error develops and markets the know error® system which utilizes bar coding, forensic principles and DNA matching to confirm that the biopsy samples being evaluated belong to the patient being diagnosed. Available for a diverse range of tissue types, including prostate, the know error® system brings new levels of patient safety and diagnostic accuracy to the biopsy evaluation process.

Since the company's launch in 2009, hundreds of physicians in a variety of specialties, including urology, have incorporated the know error® system as a standard for their patient care. To learn more about the know error® system for prostate biopsies, visit our website www.knowerror.com.